OBJECTIVE: On the basis of previous evidence that polymerase delta interacting protein 2 (Poldip2) increases reduced nicotinamide adenine dinucleotide phosphate (NADPH) oxidase 4 (Nox4) activity in vascular smooth muscle cells, we hypothesized that in vivo knockdown of Poldip2 would inhibit reactive oxygen species production and alter vascular function. APPROACH AND RESULTS: Because homozygous Poldip2 deletion is lethal, Poldip2(+/-) mice were used. Poldip2 mRNA and protein levels were reduced by ≈50% in Poldip2(+/-) aorta, with no change in p22phox, Nox1, Nox2, and Nox4 mRNAs. NADPH oxidase activity was also inhibited in Poldip2(+/-) tissue. Isolated aortas from Poldip2(+/-) mice demonstrated impaired phenylephrine and potassium chloride-induced contractions, increased stiffness, and reduced compliance associated with disruption of elastic lamellae and excessive extracellular matrix deposition. Collagen I secretion was elevated in cultured vascular smooth muscle cells from Poldip2(+/-) mice and restored by H2O2 supplementation, suggesting that this novel function of Poldip2 is mediated by reactive oxygen species. Furthermore, Poldip2(+/-) mice were protected against aortic dilatation in a model of experimental aneurysm, an effect consistent with increased collagen secretion. CONCLUSIONS: Poldip2 knockdown reduces H2O2 production in vivo, leading to increases in extracellular matrix, greater vascular stiffness, and impaired agonist-mediated contraction. Thus, unaltered expression of Poldip2 is necessary for vascular integrity and function.
OBJECTIVE: On the basis of previous evidence that polymerase delta interacting protein 2 (Poldip2) increases reduced nicotinamide adenine dinucleotide phosphate (NADPH) oxidase 4 (Nox4) activity in vascular smooth muscle cells, we hypothesized that in vivo knockdown of Poldip2 would inhibit reactive oxygen species production and alter vascular function. APPROACH AND RESULTS: Because homozygous Poldip2 deletion is lethal, Poldip2(+/-) mice were used. Poldip2 mRNA and protein levels were reduced by ≈50% in Poldip2(+/-) aorta, with no change in p22phox, Nox1, Nox2, and Nox4 mRNAs. NADPH oxidase activity was also inhibited in Poldip2(+/-) tissue. Isolated aortas from Poldip2(+/-) mice demonstrated impaired phenylephrine and potassium chloride-induced contractions, increased stiffness, and reduced compliance associated with disruption of elastic lamellae and excessive extracellular matrix deposition. Collagen I secretion was elevated in cultured vascular smooth muscle cells from Poldip2(+/-) mice and restored by H2O2 supplementation, suggesting that this novel function of Poldip2 is mediated by reactive oxygen species. Furthermore, Poldip2(+/-) mice were protected against aortic dilatation in a model of experimental aneurysm, an effect consistent with increased collagen secretion. CONCLUSIONS:Poldip2 knockdown reduces H2O2 production in vivo, leading to increases in extracellular matrix, greater vascular stiffness, and impaired agonist-mediated contraction. Thus, unaltered expression of Poldip2 is necessary for vascular integrity and function.
Authors: Min Zhang; Alison C Brewer; Katrin Schröder; Celio X C Santos; David J Grieve; Minshu Wang; Narayana Anilkumar; Bin Yu; Xuebin Dong; Simon J Walker; Ralf P Brandes; Ajay M Shah Journal: Proc Natl Acad Sci U S A Date: 2010-10-04 Impact factor: 11.205
Authors: Chiara Giannarelli; Elisabetta Bianchini; Rosa Maria Bruno; Armando Magagna; Linda Landini; Francesco Faita; Vincenzo Gemignani; Giuseppe Penno; Stefano Taddei; Lorenzo Ghiadoni Journal: Atherosclerosis Date: 2012-06-06 Impact factor: 5.162
Authors: Rui-Hai Zhou; Aleksandr E Vendrov; Igor Tchivilev; Xi-Lin Niu; Kimberly C Molnar; Mauricio Rojas; Jacqueline D Carter; Haiyan Tong; George A Stouffer; Nageswara R Madamanchi; Marschall S Runge Journal: Arterioscler Thromb Vasc Biol Date: 2011-12-22 Impact factor: 8.311
Authors: Kathryn Maiellaro-Rafferty; Daiana Weiss; Giji Joseph; William Wan; Rudolph L Gleason; W Robert Taylor Journal: Am J Physiol Heart Circ Physiol Date: 2011-05-06 Impact factor: 4.733
Authors: Steven J Forrester; Qian Xu; Daniel S Kikuchi; Derick Okwan-Duodu; Ana Carolina Campos; Elizabeth A Faidley; Guogang Zhang; Bernard Lassègue; Ruxana T Sadikot; Kathy K Griendling; Marina S Hernandes Journal: Clin Sci (Lond) Date: 2019-01-25 Impact factor: 6.124
Authors: Angélica M Amanso; Bernard Lassègue; Giji Joseph; Natalia Landázuri; James S Long; Daiana Weiss; W Robert Taylor; Kathy K Griendling Journal: Arterioscler Thromb Vasc Biol Date: 2014-05-22 Impact factor: 8.311
Authors: Noor O Baqader; Marko Radulovic; Mark Crawford; Kai Stoeber; Jasminka Godovac-Zimmermann Journal: J Proteome Res Date: 2014-09-03 Impact factor: 4.466
Authors: Qian Xu; Amol A Kulkarni; Ayyiliath M Sajith; Dilbi Hussein; David Brown; Osman F Güner; M Damoder Reddy; E Blake Watkins; Bernard Lassègue; Kathy K Griendling; J Phillip Bowen Journal: Bioorg Med Chem Date: 2017-12-17 Impact factor: 3.641
Authors: Sasa Vukelic; Qian Xu; Bonnie Seidel-Rogol; Elizabeth A Faidley; Anna E Dikalova; Lula L Hilenski; Ulrich Jorde; Leslie B Poole; Bernard Lassègue; Guogang Zhang; Kathy K Griendling Journal: Arterioscler Thromb Vasc Biol Date: 2018-10 Impact factor: 8.311
Authors: Agnes Wong; Sufang Zhang; Dana Mordue; Joseph M Wu; Zhongtao Zhang; Zbigniew Darzynkiewicz; Ernest Y C Lee; Marietta Y W T Lee Journal: Cell Cycle Date: 2013-09-03 Impact factor: 4.534